Key Statistics for BIOS
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (INR) (ttm)
|Est. EPS (INR) (03/2014)
|Est. PEG Ratio
|Market Cap (M INR)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (INR)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for BIOS
- Net Income (M/INR)
Biocon Ltd., is an integrated biotechnology enterprise with a presence in biopharmaceuticals, enzymes, custom research and clinical research. The Company's pharmaceutical products include statins, immunosuppressants and anti-diabetic drugs. Biocon also manufactures specialty enzymes and new enzyme applications besides providing clinical and custom research services.
More Company Profile & Key Executives for BIOS
|Kiran Mazumdar ShawChairman/Mng Director/Founder||John ShawVice Chairman/Founder|
|Arun Suresh ChandavarkarChief Operating Officer||Murali Krishnan K NPresident:Group Finance|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries